Kızıl, H. E. Et Al. 2023. Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways. Molecular Biology Reports , vol.50, no.4 , 3479-3488.

Kızıl, H. E., ÇAĞLAYAN, C., Darendelioğlu, E., Ayna, A., GÜR, C., Kandemir, F. M., ... KÜÇÜKLER, S.(2023). Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways. Molecular Biology Reports , vol.50, no.4, 3479-3488.

Kızıl, Hamit Et Al. "Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways," Molecular Biology Reports , vol.50, no.4, 3479-3488, 2023

Kızıl, Hamit E. Et Al. "Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways." Molecular Biology Reports , vol.50, no.4, pp.3479-3488, 2023

Kızıl, H. E. Et Al. (2023) . "Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways." Molecular Biology Reports , vol.50, no.4, pp.3479-3488.

@article{article, author={Hamit Emre Kızıl Et Al. }, title={Morin ameliorates methotrexate-induced hepatotoxicity via targeting Nrf2/HO-1 and Bax/Bcl2/Caspase-3 signaling pathways}, journal={Molecular Biology Reports}, year=2023, pages={3479-3488} }